<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2939901</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:610</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Stefan</namePart>
  <namePart type="family">Scholz</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">29131413</identifier></name>
<name type="personal">
  <namePart type="given">Wolfgang</namePart>
  <namePart type="family">Greiner</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">152704</identifier></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">21335</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Objectives

Human milk-based fortifiers have shown a protective effect on major complications for very low birth weight newborns. The current study aimed to estimate the cost-effectiveness of an exclusive human milk diet (EHMD) compared to the current approach using cow’s milk-based fortifiers in very low birth weight newborns.
Methods

A decision tree model using the health states of necrotising enterocolitis (NEC), sepsis, NEC + sepsis and no complication was used to calculate the cost-effectiveness of an EHMD. For each health state, bronchopulmonary dysplasia (BPD), retinopathy of prematurity (RoP) and neurodevelopmental problems were included as possible complications; additionally, short-bowel syndrome (SBS) was included as a complication for surgical treatment of NEC. The model was stratified into birth weight categories. Costs for inpatient treatment and long-term consequences were considered from a third party payer perspective for the reference year 2017. Deterministic and probabilistic sensitivity analyses were performed, including a societal perspective, discounting rate and all input parameter-values.
Results

In the base case, the EHMD was estimated to be cost-effective compared to the current nutrition for very low birth weight newborns with an incremental cost-effectiveness ratio (ICER) of €28,325 per Life-Year-Gained (LYG). From a societal perspective, the ICER is €27,494/LYG using a friction cost approach and €16,112/LYG using a human capital approach. Deterministic sensitivity analyses demonstrated that the estimate was robust against changes in the input parameters and probabilistic sensitivity analysis suggested that the probability EHMD was cost-effective at a threshold of €45,790/LYG was 94.8 percent.
Conclusion

Adopting EHMD as the standard approach to nutrition is a cost-effective intervention for very low birth weight newborns in Germany.
</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="journal.pone.0226496.scholz.pdf">https://pub.uni-bielefeld.de/download/2939901/2939902/journal.pone.0226496.scholz.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>Public Library of Sciences</publisher><dateIssued encoding="w3cdtf">2019</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>



<relatedItem type="host"><titleInfo><title>PLOS ONE</title></titleInfo>
  <identifier type="issn">1932-6203</identifier>
  <identifier type="eIssn">1932-6203</identifier>
  <identifier type="MEDLINE">31887150</identifier>
  <identifier type="ISI">000515092200019</identifier><identifier type="urn">urn:nbn:de:0070-pub-29399018</identifier><identifier type="doi">10.1371/journal.pone.0226496</identifier>
<part><detail type="volume"><number>14</number></detail><detail type="issue"><number>12</number></detail>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<default>Scholz S, Greiner W (2019) &lt;br /&gt;&lt;em&gt;PLOS ONE&lt;/em&gt; 14(12): e0226496.</default>
<frontiers>Scholz, S., and Greiner, W. (2019). An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. &lt;em&gt;PLOS ONE&lt;/em&gt; 14:e0226496.</frontiers>
<mla>Scholz, Stefan, and Greiner, Wolfgang. “An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany”. &lt;em&gt;PLOS ONE&lt;/em&gt; 14.12 (2019): e0226496.</mla>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Scholz, S., &amp;amp; Greiner, W. (2019). An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. &lt;em&gt;PLOS ONE&lt;/em&gt;, &lt;em&gt;14&lt;/em&gt;(12), e0226496. doi:10.1371/journal.pone.0226496&lt;/div&gt;</apa_indent>
<wels>Scholz, S.; Greiner, W. (2019): An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany &lt;em&gt;PLOS ONE&lt;/em&gt;,14:(12):e0226496</wels>
<apa>Scholz, S., &amp;amp; Greiner, W. (2019). An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. &lt;em&gt;PLOS ONE&lt;/em&gt;, &lt;em&gt;14&lt;/em&gt;(12), e0226496. doi:10.1371/journal.pone.0226496</apa>
<harvard1>Scholz, S., &amp;amp; Greiner, W., 2019. An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. &lt;em&gt;PLOS ONE&lt;/em&gt;, 14(12): e0226496.</harvard1>
<ieee> S. Scholz and W. Greiner, “An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany”, &lt;em&gt;PLOS ONE&lt;/em&gt;,  vol. 14, 2019, : e0226496.</ieee>
<angewandte-chemie>S.  Scholz, and W.  Greiner, “An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany”, &lt;em&gt;PLOS ONE&lt;/em&gt;, &lt;strong&gt;2019&lt;/strong&gt;, &lt;em&gt;14&lt;/em&gt;, : e0226496.</angewandte-chemie>
<bio1>Scholz S, Greiner W (2019) &lt;br /&gt;An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany.&lt;br /&gt;PLOS ONE 14(12): e0226496.</bio1>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Scholz, S. &amp;amp; Greiner, W. (2019). An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. &lt;em&gt;PLOS ONE&lt;/em&gt;, &lt;em&gt;14&lt;/em&gt;(12): e0226496. Public Library of Sciences. doi:10.1371/journal.pone.0226496.&lt;/div&gt;</dgps>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Scholz, Stefan, and Greiner, Wolfgang. 2019. “An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany”. &lt;em&gt;PLOS ONE&lt;/em&gt; 14 (12): e0226496.&lt;/div&gt;</chicago>
<lncs> Scholz, S., Greiner, W.: An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. PLOS ONE. 14, : e0226496 (2019).</lncs>
<ama>Scholz S, Greiner W. An exclusive human milk diet for very low birth weight newborns—A cost-effectiveness and EVPI study for Germany. &lt;em&gt;PLOS ONE&lt;/em&gt;. 2019;14(12): e0226496.</ama>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2939901</recordIdentifier><recordCreationDate encoding="w3cdtf">2020-01-13T09:38:06Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2020-03-20T12:47:52Z</recordChangeDate>
</recordInfo>
</mods>